AI and Clinical Practice—How AI Could Advance Human Heart Discoveries and Improve Care

AI and Clinical Practice—How AI Could Advance...

Up next

What's New in the Updated Lipid Guidelines?

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the New Lipid Guidelines." Related Content: What to Know About the New Lipid Guidelines 

The Health Costs of EPA's Heavy Metal Air Pollution Rollbacks

JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern." Related Content: Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern 

Recommended Episodes

How Artificial Intelligence Has Evolved and the Implications for Health Care
JAMA Clinical Reviews

The capabilities and risks of various types of artificial intelligence (AI) are markedly different. JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews author Michael Howell, MD, MPH, chief clinical officer at Google, to discuss how AI has evolved and how to ...

  Show more

Cardiac Clarity: Dr. Keith Channon Talks Revolutionizing Heart Health With AI - Ep. 212
NVIDIA AI Podcast

Here’s some news to still beating hearts: AI is helping bring some clarity to cardiology. Caristo Diagnostics has developed an AI-powered solution for detecting coronary inflammation in cardiac CT scans. In this episode of NVIDIA’s AI Podcast, Dr. Keith Channon, cofounder and chi ...  Show more

Harnessing AI: Transforming MS Care
MS Living Well: Key Info from Multiple Sclerosis Experts

Prepare to be intrigued by the groundbreaking intersection of artificial intelligence (AI) and multiple sclerosis care! By combing through extensive databases, including genetic information and real patient records, AI can forecast with remarkable accuracy th ...

  Show more

Can Omecamtiv Mecarbil Improve Peak Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)?
JAMA Author Interviews

Exercise limitation is a cardinal manifestation of heart failure with reduced ejection fraction (HFrEF), but it is not consistently improved by any of the current guideline-directed medical therapies. JAMA Deputy Editor Gregory Curfman, MD, discusses whether omecamtiv mecarbil ca ...  Show more